A combined immune prognostic index in esophageal squamous cell carcinoma patients treated with anti-PD-1 therapy.

Shoujian Ji,Chuanhua Zhao,Rongrui Liu,Yan Wang,Qing Yang, Hua Yang,Jianming Xu

Therapeutic advances in medical oncology（2023）

引用 1|浏览4

暂无评分

摘要

The CIPI score was a robust biomarker for prognostic prediction in ESCC patients treated with anti-PD-1 therapy and was immunotherapy specific. The CIPI score may also be applicable for prognostic prediction in pan-cancers.

查看译文

关键词

anti-PD-1 therapy,biomarker,clinical outcome,combined immune prognostic index,esophageal squamous cell carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要